AAIPharma, Inc.

Mar 01, 04
07:41 ET	aaiPharma Board of Directors Announces Independent Inquiry
06:58 ET	aaiPharma to Sell M.V.I.(R) Product Business to Mayne Pharma USA
Feb 19, 04
09:26 ET	aaiPharma Announces FDA Approval of M.V.I. Adult(TM) (Multi-Vitamin Infusion), Pharmacy Bulk Package
Feb 17, 04
16:47 ET	aaiPharma Named in Shareholder Lawsuit
Feb 13, 04
10:56 ET	aaiPharma Receives FDA Approval for New Methadone Label
Feb 12, 04
11:19 ET	aaiPharma Inc. Announces Change in Management
Feb 05, 04
07:30 ET	aaiPharma Inc. Reports 2003 Financial Results
Jan 23, 04
08:30 ET	aaiPharma Inc. to Present at Piper Jaffray Health Care Conference
Jan 21, 04
17:28 ET	aaiPharma Inc. Announces Fourth Quarter and Full-Year 2003 Earnings Release, Conference Call, and Web Cast
Jan 15, 04
10:00 ET	New Drug Application Submitted for Once-Daily Allegra-D(R) (fexofenadine HCl 180 mg/pseudoephedrine HCl 240 mg) Formulation Using aaiPharma's Development Expertise
Jan 06, 04
17:13 ET	aaiPharma Inc. Announces Two Executive Promotions and Organizational Restructuring
Dec 12, 03
08:00 ET	aaiPharma Inc. Provides Financial Guidance for 2004
Dec 05, 03
18:00 ET	aaiPharma to Present at First Albany Corporation Annual Growth Conference
Dec 02, 03
10:58 ET	aaiPharma Announces Completion of Acquisition of Pain Products
Nov 24, 03
07:01 ET	aaiPharma Added to Nasdaq Biotechnology Index
Nov 06, 03
17:02 ET	aaiPharma to Present at CIBC World Markets Healthcare Conference
Nov 04, 03
07:31 ET	aaiPharma Announces Exclusive License Agreement With Salix Pharmaceuticals for Azasan(R)
Nov 03, 03
16:33 ET	aaiPharma Focused on Independent Growth Strategy; Merger Agreement With CIMA Terminated
Oct 22, 03
18:40 ET	aaiPharma Inc. Reports Record 2003 Third Quarter Financial Results
09:33 ET	aaiPharma to Acquire Pain Products From Elan Corporation, plc; Acquisition Will Be Accretive Upon Launch of Products
Oct 08, 03
08:30 ET	aaiPharma Announces Third Quarter 2003 Earnings Release, Web Cast, And Conference Call
Oct 07, 03
08:14 ET	Aaipharma Announces National Launch of Darvocet A500(TM)
Sep 19, 03
08:53 ET	aaiPharma Issues Statement in Response to Announcement by CIMA Labs Regarding Alternative Cephalon Proposal
Sep 11, 03
10:23 ET	aaiPharma Announces FDA Approval of Darvocet A500(TM)
09:14 ET	aaiPharma Issues Statement in Response to CIMA's Announcement of New Letter From Cephalon
Aug 27, 03
09:01 ET	aaiPharma Learning Center Accredited by NAEYC and Earns Five-Star License From State of North Carolina Division of Child Development
Aug 26, 03
08:28 ET	aaiPharma Unveils New Web Page Devoted to IMS Pipeline Data
Aug 21, 03
11:40 ET	aaiPharma Issues Statement in Response to Unsolicited Proposal Received By CIMA LABS
Jul 23, 03
17:27 ET	aaiPharma Inc. Announces Record 2003 Earnings and Revenues in the Second Quarter Driven by Pharmaceutical Product Sales
Jul 17, 03
16:16 ET	aaiPharma Announces Second Quarter 2003 Earnings Release, Web Cast, and Conference Call
07:30 ET	aaiPharma Announces Acquisition of Unique Darvocet(TM) Line Extension
Jun 25, 03
16:27 ET	aaiPharma Announces SNDA Filing for Brethine(R) Ampuls
Jun 24, 03
08:27 ET	aaiPharma Announces Launch of Darvon(R) Compound 32
Jun 19, 03
14:00 ET	aaiPharma to Present at Wachovia Securities Equity Conference
Jun 12, 03
08:00 ET	aaiPharma to Present at Thomas Weisel Partners Growth Forum
Jun 05, 03
10:15 ET	aaiPharma and the Yahweh Center Children's Village Break Ground on Region's First-Ever Adoption Readiness Cottage
May 28, 03
18:36 ET	aaiPharma to Present at UBS Warburg Global Specialty Pharmaceuticals Conference
17:58 ET	aaiPharma to Present at UBS Warburg Global Specialty Pharmaceuticals
May 22, 03
08:34 ET	aaiPharma Announces CBE-30 Filing for First Darvon(R) Line Extension
May 01, 03
17:00 ET	aaiPharma to Present at Deutsche Bank Securities 2003 Health Care Conference
Apr 23, 03
17:28 ET	aaiPharma to Present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference
Apr 21, 03
07:37 ET	aaiPharma Reports Record Revenues for First Quarter 2003
Apr 16, 03
12:26 ET	aaiPharma Announces Acquisition of Injectable Treatment for Severe Pain
Apr 15, 03
17:00 ET	aaiPharma Inc. Announces First Quarter 2003 Earnings Release, Web Cast, And Conference Call
Apr 01, 03
08:05 ET	aaiPharma and SICOR Announce Co-Promotion Alliance for Calcitriol
Mar 27, 03
09:19 ET	aaiPharma Announces Launch of Azasan(TM) 75 mg and 100 mg
Mar 25, 03
07:30 ET	aaiPharma Launches Calcitriol Injection
Mar 21, 03
07:00 ET	aaiPharma to Present at Banc of America Securities Healthcare Conference
Mar 19, 03
11:34 ET	aaiPharma Announces Web Cast to Discuss 2002 Product Performance; Company Reaffirms 2003 First Quarter and Full Year Financial Guidance
Mar 18, 03
17:25 ET	aaiPharma Announces New Web Site Content Focused on Frequently Asked Questions Regarding Product Performance
Mar 12, 03
07:30 ET	aaiPharma Announces NDA Submission to FDA for M.V.I. Adult(TM)
Feb 27, 03
16:30 ET	aaiPharma to Present at Lehman Brothers Global Healthcare Conference
Feb 26, 03
16:30 ET	aaiPharma to Present at Salomon Smith Barney Specialty Pharmaceuticals Conference
Feb 24, 03
16:30 ET	aaiPharma to Present at Raymond James Institutional Investors Conference
Feb 20, 03
14:00 ET	aaiPharma Receives FDA Approval and Shared Market Exclusivity For Calcitriol Injection